9965 Federal Drive
Colorado Springs, CO 80921
News | EP Lab | September 27, 2017
Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a blocked guidewire lumen in...
Technology | Drug-Eluting Balloons | July 26, 2017
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the...
Feature | EP Lab | June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Videos | EP Lab | May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Feature | EP Lab | May 17, 2017 | Dave Fornell
May 17, 2017 — A new intravenous occlusion balloon designed to seal any accidental tears in the superior vena cava (S
News | Thrombectomy Devices | January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
News | Drug-Eluting Balloons | December 06, 2016
December 6, 2016 — The Spectranetics Corp.
News | May 06, 2015
The Spectranetics Corporation announced it is accelerating investments in the Stellarex drug-coated balloon angioplasty...
Feature | September 26, 2014
The first large prospective study to examine the effectiveness of laser atherectomy in the treatment of femoropopliteal...
Technology | April 15, 2014
April 15, 2014 — The Spectranetics Corp. announced U.S. Food and Drug Administration (FDA) clearance of two new...